Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Supernus Pharmaceuticals, Inc..

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Sell	1.6M	1.6M	-13K	€28.30–€38.00
2024-Q4	Sell	1.7M	1.6M	-130K	€28.80–€36.00
2024-Q3	Buy	1.7M	1.7M	+44K	€24.00–€32.00
2024-Q2	Buy	1.3M	1.7M	+352K	€24.40–€30.80
2024-Q1	Sell	1.4M	1.3M	-45K	€25.00–€32.60
2023-Q4	Sell	1.4M	1.4M	-60K	€21.40–€26.40
2023-Q3	Sell	1.5M	1.4M	-58K	€25.80–€30.20
2023-Q2	Buy	1.4M	1.5M	+103K	€22.60–€34.00
2023-Q1	Buy	1.3M	1.4M	+133K	€31.80–€38.20
2022-Q4	Sell	1.3M	1.3M	-20K	€32.00–€36.00
2022-Q3	Sell	1.4M	1.3M	-117K	€28.15–€35.60
2022-Q2	Buy	1.2M	1.4M	+154K	€24.00–€31.20
2022-Q1	Buy	1.2M	1.2M	+4.4K	€25.20–€29.00
2021-Q4	Sell	1.4M	1.2M	-150K	€22.40–€29.80
2021-Q3	Sell	1.5M	1.4M	-128K	€20.20–€26.40
2021-Q2	Sell	1.8M	1.5M	-244K	€22.00–€27.40
2021-Q1	Sell	1.8M	1.8M	-89K	€19.50–€25.40
2020-Q4	Sell	1.9M	1.8M	-19K	€14.70–€22.40
2020-Q3	Buy	1.6M	1.9M	+276K	€17.10–€21.60
2020-Q2	Buy	902K	1.6M	+691K	€15.40–€22.40
2020-Q1	Sell	921K	902K	-19K	€13.30–€22.20
2019-Q4	Buy	562K	921K	+359K	€17.90–€25.80
2019-Q3	Sell	604K	562K	-42K	€23.06–€30.17
2019-Q2	Buy	462K	604K	+142K	€26.39–€34.46
2019-Q1	Buy	344K	462K	+119K	€28.32–€36.08
2018-Q4	Sell	468K	344K	-124K	€27.56–€42.95
2018-Q3	Buy	304K	468K	+164K	€37.26–€51.25
2018-Q1	Buy	26K	304K	+278K	€29.55–€38.00
2017-Q4	Sell	125K	26K	-99K	€30.17–€36.07
2015-Q3	Buy	115K	125K	+10K
2015-Q2	Sell	157K	115K	-42K
2014-Q4	Buy	37K	157K	+120K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors